Abstract
Objectives Video consultations (VCs) have been rapidly implemented in response to Covid-19. However, limited research has explored patient experiences of VCs in this context. This research therefore explored patient experiences of VCs during their early stages of implementation in response to Covid-19.
Design Secondary data analysis of routine patient survey responses using descriptive statistics and inductive thematic analysis.
Setting and participants 955 (22.6%) survey responses following a VC using Attend Anywhere in a rural, aging and outpatient care setting between June and July 2020.
Results Most (93.2%) respondents reported having ‘good’ (n=210, 22.0%), or ‘very good’ (n=680, 71.2%) experiences with VCs. Most respondents accessed their VC alone (n=806, 84.4%), except for those aged 71+ (n=23/58, 39.7%). Most participants reported feeling listened to and understood (n=904, 94.7%), felt their needs had been met (n=860, 90.1%) and were able to communicate everything they wanted (n=848, 88.8%). Satisfaction with communication was very strongly associated with satisfaction with the technical performance of the VC (p<0.001). Free text responses had three key themes: i) barriers to VC use including technological difficulties, quality of patient information and accessibility or suitability concerns; ii) potential benefits including reduced stress and anxiety, enhanced accessibility, cost and time savings; and iii) patient suggested improvements including trial calls, turning music off, facilitating photo uploads, expanding written character limit and supporting other internet browsers. Most (92.1%) participants were likely to choose a VC again in the future.
Conclusions The vast majority of respondents reported positive experiences of VCs. Identified benefits of enhanced accessibility, affordability, time, monetary and environmental savings are particularly interesting for future service delivery. Further research is needed, using rapid co-design techniques, to improve feedback methods, patient information and experience to support sustainability and to address accessibility and experience of patients excluded from this work, through lack of VC access.
Strengths and limitations of this study
Large data set of “real world” patient feedback during the early stages of video consultation use in response to Covid-19.
Findings from this research provide important and early insights into patient experiences of video consultations following their rapid implementation in response to Covid-19.
Quantitative and qualitative insight into patient experience, barriers, benefits and suggested improvements.
Secondary data means we are unable to identify patients providing multiple responses.
Feedback was collected from patients who had successfully completed a video consultation, data may therefore contain positive bias.
Experiences or barriers for individuals who have not been able to, or chosen not to use video consultations currently remain unknown.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study was not a clinical trial, but used secondary data collected by the partner NHS Trust
Funding Statement
Funding statement: This work was supported by the EPIC (eHealth Productivity and Innovation in Cornwall and the Isle of Scilly) project which was part funded by the European Regional Development Fund. Additional funding for the EPIC project was received from University of Plymouth. ERDF Grant number [05R18P02814].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval to conduct this secondary analysis and complete further primary data collection was attained from the Health Research Authority (HRA) and Health and Care Research Wales (HCRW), IRAS ID 286543.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
rebecca.baines{at}plymouth.ac.uk, katie.edwards{at}plymouth.ac.uk, sebastian.stevens{at}plymouth.ac.uk, kate.atkinson3{at}nhs.net, ellen.wilkinson{at}nhs.net, ray.jones{at}plymouth.ac.uk, arunangsu.chatterjee{at}plymouth.ac.uk
Data Availability
Data sharing statement: Not all patients have consented for their comments to be published, thus the full dataset is not available publicly, but interested parties may enquire with the authors for further details.
